Revenue and net profit saw strong year-over-year and sequential growth, with improved margins and robust segment performance, especially in Speciality Chemicals. The group is monitoring regulatory changes, including new labour codes, and granted significant stock options during the quarter.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.